Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Read
871
Timeswas read the article
364
Total PDF
507
Total HTML
Share statistics
array:24 [ "pii" => "S1665268119301024" "issn" => "16652681" "doi" => "10.5604/01.3001.0010.7530" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "70003" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2018;17:11-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 103 "formatos" => array:3 [ "EPUB" => 10 "HTML" => 43 "PDF" => 50 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119301036" "issn" => "16652681" "doi" => "10.5604/01.3001.0010.7531" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "70004" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2018;17:14-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 124 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 49 "PDF" => 62 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "14" "paginaFinal" => "17" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vania Cruz-Ramón, Paulina Chinchilla-López, Oscar Ramírez-Pérez, Xingshun Qi, Nahum Méndez-Sánchez" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Vania" "apellidos" => "Cruz-Ramón" ] 1 => array:2 [ "nombre" => "Paulina" "apellidos" => "Chinchilla-López" ] 2 => array:2 [ "nombre" => "Oscar" "apellidos" => "Ramírez-Pérez" ] 3 => array:2 [ "nombre" => "Xingshun" "apellidos" => "Qi" ] 4 => array:2 [ "nombre" => "Nahum" "apellidos" => "Méndez-Sánchez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119301036?idApp=UINPBA00004N" "url" => "/16652681/0000001700000001/v2_201905311150/S1665268119301036/v2_201905311150/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119301012" "issn" => "16652681" "doi" => "10.5604/01.3001.0010.7529" "estado" => "S300" "fechaPublicacion" => "2018-01-01" "aid" => "70002" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2018;17:8-10" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 94 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 35 "PDF" => 52 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "8" "paginaFinal" => "10" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordan J. Feld" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jordan J." "apellidos" => "Feld" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119301012?idApp=UINPBA00004N" "url" => "/16652681/0000001700000001/v2_201905311150/S1665268119301012/v2_201905311150/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "11" "paginaFinal" => "13" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Aybike Birerdinc, Zobair M. Younossi" "autores" => array:2 [ 0 => array:3 [ "nombre" => "Aybike" "apellidos" => "Birerdinc" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">**</span>" "identificador" => "aff0010" ] ] ] 1 => array:4 [ "nombre" => "Zobair M." "apellidos" => "Younossi" "email" => array:1 [ 0 => "Zobair.Younossi@inova.org" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">**</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Medicine and Center for Liver Diseases, Inova Fairfax Hospital, USA" "etiqueta" => "*" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, USA" "etiqueta" => "**" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Corresponding author." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="s0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0015">Opinion</span><p id="p0005" class="elsevierStylePara elsevierViewall">Non-alcoholic Fatty Liver Disease (NAFLD) is a metabolic disorder characterized by the presence of ectopic fat in hepatocytes.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> It is estimated that NAFLD affects 24.5% of the World population.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Since the prevalence of NAFLD increases proportionally with the presence of diabetes and obesity, this global epidemic is projected to double by 2030.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> The NAFLD spectrum ranges from hepatic steatosis to steatosis with hepatocellular inflammation and damage (nonalcoholic steatohepatitis: NASH) which is the subtype that can progress with the development of fibrosis, in some rare cases, to hepatocellular carcinoma (HCC).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> NASH is rapidly becoming one of the most common indication for liver transplantation.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> The most important clinical predictor of adverse outcome is presence of diabetes mellitus (DM), while stage of hepatic fibrosis is the most important histologic predictor of mortality.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a>,<a class="elsevierStyleCrossRefs" href="#bib0025">5</a>–<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> In addition to its clinical impact, NAFLD has a substantial economic impact to the society.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="p0010" class="elsevierStylePara elsevierViewall">Many pathways have been implicated in the pathogenesis of NAFLD, such as insulin resistance and enhanced oxidative stress. These studies suggest that NASH is a phenotype that can involve multiple environmental, genetic and epigenetic factors.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Despite increased awareness, it remains challenging to quantify the true prevalence of NASH in the general population. While the use of liver ultrasound can accurately establish hepatic steatosis, liver biopsy remains the most reliable “gold standard” for diagnosis of NASH and to stage hepatic fibrosis.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Thus, the growing epidemic of NAFLD and most importantly, NASH with fibrosis, urgently necessitates reliable and accurate non-invasive biomarkers that have a high degree of disease stage specificity.</p><p id="p0015" class="elsevierStylePara elsevierViewall">In the current study <span class="elsevierStyleItalic">Epigenome-Wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis</span>, Nano, <span class="elsevierStyleItalic">et al.</span> assess the differential DNA methylation levels and their association with circulating levels of liver enzymes and hepatic steatosis, as assessed by ultrasound, in several cohorts of the Rotterdam Study.</p><p id="p0020" class="elsevierStylePara elsevierViewall">The authors conduct an epigenome-wide association study (EWAS) using whole blood to determine liver enzyme levels: gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). The same markers are assessed in two separate cohorts, the “<span class="elsevierStyleItalic">discovery set</span>” (n = 731) and the “replication set” n = 719. The study analyzes significant DNA methylation changes and evaluates their relation with hepatic steatosis by using generalized linear mixed effects models that include the following factors: age, sex, smoking history, and whole blood cells proportions, body mass index, alcohol consumption, coffee intake, hypertension medication, lipid levels, glucose levels and liver enzymes.</p><p id="p0025" class="elsevierStylePara elsevierViewall">Additionally, the authors determine the expression levels of the genes identified in the previous experiment in 9 human hepatoma cell lines (Hep3B, Huh6, Huh7, PLC/ PRF/5, SNU182, SNU398, SNU449, HepG2 and HepaRG) and correlate these with potential targets associated with lipid traits. They confirm the cellular effects of these candidate genes by knock-down studies using lentiviral vectors expressing small hairpin RNAs.</p><p id="p0030" class="elsevierStylePara elsevierViewall">The results of this study provide some interesting associations and insight about NAFLD. Briefly, the authors found 8 CpG sites annotated to 7 unique loci (SLC7A11, SLC1A5, SLC43A1, PHGDH, PSORS1C1, SREBF1, ANKS3) associated with GGT but only 1 probe annotated to SLC7A11, associated with ALT. Interestingly, no probe was identified for AST. In the replication group 4 probes associated with GGT levels (SLC7A11, SLC43A1, SLC1A5 and PHGDH), and 1 for ALT levels (SLC7A11). Importantly, the authors found an association between DNA methylation at SLC7A11 with reduced risk of hepatic steatosis in participants as measured by ultrasound. The cell culture experiments showed SLC7A11 to be highly expressed in human hepatoma cell lines with a positive correlation with the expression of a panel of lipid-associated genes. However, it must be noted that elevated levels of SLC7A11 were found in HCC patients with shorter overall survival time,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> suggesting that the levels of SLC7A11 seen in this cell culture study may be a feature of the cell lines, rather than the mechanism of lipid deregulation seen in hepatic steatosis.</p><p id="p0035" class="elsevierStylePara elsevierViewall">Based on these observations the authors suggest a significant role for SLC7A11 in both lipid metabolism and hepatic steatosis. SLC7A11 is a member of a heteromeric, sodium-independent, anionic amino acid transport system, highly specific for cysteine and glutamate. SLC7A11 has been shown to be differentially methylated in correlation with trigylceride levels,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> but mostly studied in gliomas and aggressiveness of glioblastomas.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>,<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> In fact, SLC7A11 has been implicated in numerous cancers via the enhancement of cancer cell glucose dependence.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><p id="p0040" class="elsevierStylePara elsevierViewall">However, more relevant to the field of NASH, novel studies have shown SLC7A11 to be involved in a type of iron and ROS dependent regulated cell death, ferroptosis.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> This process has been observed in both cancer and normal cells (notably T-cells and fibroblasts) and functions via the activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition SLC7A11, as well as accumulation of lipid peroxidation products and lethal reactive oxygen species (ROS) derived from iron metabolism.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Interestingly, p53 inhibits SLC7A11 expression and induces ferroptosis following ROS-induced stress, potentially explaining the involvement of this gene in both cancer etiologies and lipid metabolism.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> Within the context of NAFLD, lipid peroxidation has been suspected to be involved in causing hepatocyte injury and fibrosis.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> These lines of research suggest an intricate role for SLC7A11 in NAFLD and possibly a novel mechanism in which the deregulation of a cell-death pathway may contribute to NAFLD progression. Regrettably, the use of ultrasound rather than liver tissue biopsy in this study, limits the conjecture one can make with regard to the role of SLC7A11 in the development of NASH and related fibrosis.</p><p id="p0045" class="elsevierStylePara elsevierViewall">Despite the intriguing results in this EWAS, one must remember that DNA methylation was performed using the whole blood. Extensive reporting has shown substantial differences between CpG methylation of blood and tissue cells<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> and therefore these results must be interpreted with caution.</p><p id="p0050" class="elsevierStylePara elsevierViewall">Although this study provides some novel insights for investigation, it does not address the most important predictor of long term outcomes in NAFLD, i.e. stage of hepatic fibrosis. Non-invasive biomarkers that can reliably predict stage of fibrosis and its progression over time can have significant prognostic and therapeutic implications. While this study provides insights about the pathogenesis of NAFLD using novel technologies, to be clinically relevant and meet the challenge of this growing epidemic, future studies must focus on NASH and its associated fibrosis.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:3 [ "identificador" => "xres1198055" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abs0010" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1116699" "titulo" => "Key words" ] 2 => array:2 [ "identificador" => "s0005" "titulo" => "Opinion" ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-12-06" "fechaAceptado" => "2017-12-06" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec1116699" "palabras" => array:3 [ 0 => "NASH" 1 => "NAFLD" 2 => "EWAS" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abs0010" class="elsevierStyleSection elsevierViewall"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Non-alcoholic Fatty Liver Disease (NAFLD) and its progressive form or NASH with fibrosis, are rapidly increasing in conjunction with the growing rates of obesity and type II diabetes. Novel technologies such as epigenome-wide association studies (EWAS) may provide opportunities to get valuable insight into not only the mechanisms of disease, but to also discover potential biomarker targets with clinical relevance to disease stage.</p></span>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0010" "bibliografiaReferencia" => array:19 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Sayiner M." 1 => "Koenig A." 2 => "Henry L." 3 => "Younossi Z.M." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cld.2015.10.001" "Revista" => array:6 [ "tituloSerie" => "Clin Liver Dis" "fecha" => "2016" "volumen" => "20" "paginaInicial" => "205" "paginaFinal" => "214" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27063264" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Younossi Z.M." 1 => "Koenig A.B." 2 => "Abdelatif D." 3 => "Fazel Y." 4 => "Henry L." 5 => "Wymer M." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.28431" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2016" "volumen" => "64" "paginaInicial" => "73" "paginaFinal" => "84" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26707365" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Younossi Z.M." 1 => "Otgonsuren M." 2 => "Henry L." 3 => "Venkatesan C." 4 => "Mishra A." 5 => "Erario M." 6 => "Hunt S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepatology" "fecha" => "2015" "volumen" => "62" "paginaInicial" => "1723" "paginaFinal" => "1730" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wong R.J." 1 => "Aguilar M." 2 => "Cheung R." 3 => "Perumpail R.B." 4 => "Harrison S.A." 5 => "Younossi Z.M." 6 => "Ahmed A." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gastroenterology" "fecha" => "2015" "volumen" => "148" "paginaInicial" => "547" "paginaFinal" => "555" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev <span class="elsevierStyleItalic">Gastroenterol Hepatol.</span> 2017 [Epub ahead of print]" ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Dulai P.S." 1 => "Singh S." 2 => "Patel J." 3 => "Soni M." 4 => "Prokop L.J." 5 => "Younossi Z." 6 => "Sebastiani G." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.29085" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2017" "volumen" => "65" "paginaInicial" => "1557" "paginaFinal" => "1565" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28130788" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Younossi Z.M." 1 => "Stepanova M." 2 => "Rafiq N." 3 => "Makhlouf H." 4 => "Younoszai Z." 5 => "Agrawal R." 6 => "Goodman Z." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.24268" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2011" "volumen" => "53" "paginaInicial" => "1874" "paginaFinal" => "1882" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21360720" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Younossi Z.M." 1 => "Blissett D." 2 => "Blissett R." 3 => "Henry L." 4 => "Stepanova M." 5 => "Younossi Y." 6 => "Racila A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.28785" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2016" "volumen" => "64" "paginaInicial" => "1577" "paginaFinal" => "1586" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27543837" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. <span class="elsevierStyleItalic">Hepatology.</span> 2017 [Epub ahead of print]." ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Zhang L, Huang Y, Zhu Y, Yu Z, Shao M, Luo Y. Identification and Characterization of Cadmium-Related Genes in Liver Carcinoma. <span class="elsevierStyleItalic">Biol Trace Elem Res.</span> 2017 [Epub ahead of print]." ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Sayols-Baixeras S." 1 => "Subirana I." 2 => "Lluis-Ganella C." 3 => "Civeira F." 4 => "Roquer J." 5 => "Do A.N." 6 => "Absher D." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/hmg/ddw285" "Revista" => array:6 [ "tituloSerie" => "Hum Mol Genet" "fecha" => "2016" "volumen" => "25" "paginaInicial" => "4556" "paginaFinal" => "4565" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28173150" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetics in Brain Tumors: HDACs Take Center Stage" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Eyüpoglu I.Y." 1 => "Savaskan N.E." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Neuropharmacol" "fecha" => "2016" "volumen" => "14" "paginaInicial" => "48" "paginaFinal" => "54" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26521944" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Takeuchi S." 1 => "Wada K." 2 => "Toyooka T." 3 => "Shinomiya N." 4 => "Shimazaki H." 5 => "Nakanishi K." 6 => "Nagatani K." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1227/NEU.0b013e318270d9de" "Revista" => array:6 [ "tituloSerie" => "Neurosurgery" "fecha" => "2013" "volumen" => "72" "paginaInicial" => "33" "paginaFinal" => "41" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23254810" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Koppula P." 1 => "Zhang Y." 2 => "Shi J." 3 => "Li W." 4 => "Gan B." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M117.798405" "Revista" => array:6 [ "tituloSerie" => "J Biol Chem" "fecha" => "2017" "volumen" => "292" "paginaInicial" => "14240" "paginaFinal" => "14249" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28630042" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ferroptosis: an iron-dependent form of nonapoptotic cell death" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Dixon S.J." 1 => "Lemberg K.M." 2 => "Lamprecht M.R." 3 => "Skouta R." 4 => "Zaitsev E.M." 5 => "Gleason C.E." 6 => "Patel D.N." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cell.2012.03.042" "Revista" => array:6 [ "tituloSerie" => "Cell" "fecha" => "2012" "volumen" => "149" "paginaInicial" => "1060" "paginaFinal" => "1072" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22632970" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ferroptosis: process and function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Xie Y." 1 => "Hou W." 2 => "Song X." 3 => "Yu Y." 4 => "Huang J." 5 => "Sun X." 6 => "Kang R." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/cdd.2015.158" "Revista" => array:6 [ "tituloSerie" => "Cell Death Differ" "fecha" => "2016" "volumen" => "23" "paginaInicial" => "369" "paginaFinal" => "379" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26794443" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ferroptosis as a p53-mediated activity during tumour suppression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Jiang L." 1 => "Kon N." 2 => "Li T." 3 => "Wang S.J." 4 => "Su T." 5 => "Hibshoosh H." 6 => "Baer R." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nature" "fecha" => "2015" "volumen" => "520" "paginaInicial" => "57" "paginaFinal" => "62" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "MacDonald G.A." 1 => "Bridle K.R." 2 => "Ward P.J." 3 => "Walker N.I." 4 => "Houglum K." 5 => "George D.K." 6 => "Smith J.L." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Gastroenterol Hepatol" "fecha" => "2001" "volumen" => "16" "paginaInicial" => "599" "paginaFinal" => "606" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11422610" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Reinius L.E." 1 => "Acevedo N." 2 => "Joerink M." 3 => "Pershagen G." 4 => "Dahlén S.E." 5 => "Greco D." 6 => "Söderhäll C." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0041361" "Revista" => array:5 [ "tituloSerie" => "PLoS One" "fecha" => "2012" "volumen" => "7" "paginaInicial" => "e41361" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22848472" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001700000001/v2_201905311150/S1665268119301024/v2_201905311150/en/main.assets" "Apartado" => array:4 [ "identificador" => "77720" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Opinion" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001700000001/v2_201905311150/S1665268119301024/v2_201905311150/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119301024?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 3 | 3 | 6 |
| 2024 September | 7 | 4 | 11 |
| 2024 August | 7 | 3 | 10 |
| 2024 July | 8 | 2 | 10 |
| 2024 June | 7 | 5 | 12 |
| 2024 May | 6 | 5 | 11 |
| 2024 April | 8 | 3 | 11 |
| 2024 March | 29 | 3 | 32 |
| 2024 February | 19 | 5 | 24 |
| 2024 January | 9 | 5 | 14 |
| 2023 December | 5 | 7 | 12 |
| 2023 November | 7 | 5 | 12 |
| 2023 October | 13 | 7 | 20 |
| 2023 September | 3 | 0 | 3 |
| 2023 August | 5 | 5 | 10 |
| 2023 July | 7 | 7 | 14 |
| 2023 June | 4 | 1 | 5 |
| 2023 May | 3 | 5 | 8 |
| 2023 April | 9 | 4 | 13 |
| 2023 March | 5 | 4 | 9 |
| 2023 February | 1 | 1 | 2 |
| 2023 January | 6 | 5 | 11 |
| 2022 December | 6 | 3 | 9 |
| 2022 November | 11 | 5 | 16 |
| 2022 October | 7 | 7 | 14 |
| 2022 September | 12 | 4 | 16 |
| 2022 August | 9 | 8 | 17 |
| 2022 July | 10 | 10 | 20 |
| 2022 June | 21 | 12 | 33 |
| 2022 May | 7 | 8 | 15 |
| 2022 April | 4 | 5 | 9 |
| 2022 March | 10 | 5 | 15 |
| 2022 February | 7 | 9 | 16 |
| 2022 January | 13 | 2 | 15 |
| 2021 December | 6 | 9 | 15 |
| 2021 November | 8 | 7 | 15 |
| 2021 October | 9 | 11 | 20 |
| 2021 September | 10 | 7 | 17 |
| 2021 August | 4 | 6 | 10 |
| 2021 July | 6 | 6 | 12 |
| 2021 June | 7 | 7 | 14 |
| 2021 May | 9 | 6 | 15 |
| 2021 April | 27 | 17 | 44 |
| 2021 March | 6 | 4 | 10 |
| 2021 February | 11 | 7 | 18 |
| 2021 January | 6 | 8 | 14 |
| 2020 December | 5 | 5 | 10 |
| 2020 November | 5 | 8 | 13 |
| 2020 October | 16 | 4 | 20 |
| 2020 September | 10 | 7 | 17 |
| 2020 August | 7 | 5 | 12 |
| 2020 July | 5 | 11 | 16 |
| 2020 June | 5 | 3 | 8 |
| 2020 May | 9 | 7 | 16 |
| 2020 April | 2 | 2 | 4 |
| 2020 March | 2 | 0 | 2 |
| 2020 February | 2 | 1 | 3 |
| 2020 January | 7 | 3 | 10 |
| 2019 December | 5 | 9 | 14 |
| 2019 November | 4 | 2 | 6 |
| 2019 September | 2 | 3 | 5 |
| 2019 August | 2 | 1 | 3 |
| 2019 July | 3 | 5 | 8 |
| 2019 June | 3 | 6 | 9 |
| 2019 May | 16 | 20 | 36 |
Show all
